News Release

A modified protein appears to trigger lung fibrosis after environmental exposure

Researchers find a role for citrullinated vimentin as a damage-associated molecular pattern molecule, or DAMP, that is generated by lung macrophages in response to environmental cadmium/carbon black.

Peer-Reviewed Publication

University of Alabama at Birmingham

Veena Antony

image: Veena Antony view more 

Credit: UAB

BIRMINGHAM, Ala. - The triggers and causes of a severe scarring disease of the lungs -- idiopathic pulmonary fibrosis, or IPF -- remain unclear.

Now research published in Science Translational Medicine shows how cadmium and carbon black can trigger lung macrophages to produce a modified protein, citrullinated vimentin, or cit vim, which leads to lung fibrosis. Researchers from the University of Alabama at Birmingham and three other American universities also describe a sequence of mechanistic steps in lung macrophages and lung fibroblasts that leads to the lung scarring.

One of the enzymes involved in these steps -- peptidylarginine deiminase 2, or PAD2 -- may be a promising target to attenuate cadmium/carbon black-induced fibrosis, they say. The researchers also report a potential disease model for lung fibrosis and IPF -- the use of cadmium chloride to induce interstitial fibrosis in mice.

The study, led by Veena Antony, M.D., included patients with IPF, tissue experiments and mouse models. Antony is the Endowed Professor of Environmental Medicine in the UAB Department of Medicine, and she directs the UAB Superfund Research Program.

"Altogether, these studies support a role for cit-vim as a damage-associated molecular pattern molecule, or DAMP, that is generated by lung macrophages in response to environmental cadmium/carbon black exposure," Antony said. Cadmium is a toxic heavy metal recognized as a cause of lung fibrosis. Cadmium can adsorb onto carbon black particles. In the lung, such particles are ingested by macrophages, the sentinel host defense cells of the mammalian lung. Up to two-thirds of IPF patients have a history of smoking, and cigarette smoke contains both cadmium and carbon black. Air pollution from biomass fuels and coal furnaces is also a source of the two pollutants.

Data from human subjects

The researchers evaluated cadmium and cit-vim accumulation in tissue, using lung biopsies from 25 subjects with IPF -- eight never-smokers and 17 smokers -- and 14 controls -- eight never-smokers and six smokers.

Researchers found that both cadmium and carbon black were significantly accumulated in the lung tissue from IPF subjects. Furthermore, the cadmium concentrations in the IPF lung tissues directly correlated with cit-vim amounts, and the cit-vim amounts were higher in smoker IPF tissue compared to non-smoker IPF tissue. Also, subjects with IPF had higher levels of cit-vim in plasma, and those amounts inversely correlated with lung function. Lung macrophages from subjects with IPF had significantly increased vimentin and cit-vim expression compared to macrophages from controls. Vimentin is a structural protein in animal cells.

Data from human tissues

Using lung macrophages from subjects with IPF, researchers found that cadmium/carbon black induced citrullination of vimentin, and secretion of cit-vim from lung macrophages was dependent on activation of two enzymes, Akt1 and PAD2. Citrullination is the attachment of the amino acid citrulline onto a protein.

Cit-vim that was isolated and purified from lung macrophages was able to induce invasion of pulmospheres by primary lung fibroblasts from normal subjects. Cit-vim enhanced the expression of collagen by the fibroblasts, and the expression of collagen by lung fibroblasts from IPF subjects was even greater. The pulmospheres -- 3-dimensional spheroids -- were derived from normal lung tissue. Fibroblast proliferation and excessive collagen deposition are part of lung scarring in IPF.

DAMPs are molecules from damaged or dying cells that provoke an innate immune response to clean up the damage. Researchers showed that cit-vim acted as a DAMP to activate fibroblasts through toll-like receptor 4 signaling. The activated fibroblasts produced profibrotic cytokines, contributing to the pathogenesis of IPF.

Thus, the data emphasize a critical role for lung macrophages in the development of lung fibrosis.

Data from mice

In animals, researchers found that mice treated with cit-vim, but not normal vimentin, independently developed lung fibrosis, with architectural destruction and increased collagen deposition, in a toll-like receptor 4-dependent fashion. Wild-type mice exposed to cadmium/carbon black -- but not mouse mutants lacking PAD2 or toll-like receptor 4 -- generated high amounts of cit-vim in plasma and in bronchoalveolar lavage fluid, and the mice developed lung fibrosis.

"This finding is important," Antony said, "because cit-vim is sufficient to provoke fibroblast activation in vitro and elicit profibrotic cytokine/chemokine production and TLR4-dependent lung fibrosis in vivo.

"Our data demonstrate that cadmium/carbon black is a risk factor, not only in subjects with IPF who smoked, but also in nonsmokers. Higher concentrations of cadmium in patients who do not smoke may be caused by exposure to cadmium through food and/or occupation or environment."


Co-authors with Antony in the study, "Citrullinated vimentin mediates development and progression of lung fibrosis," are Fu Jun Li, Ranu Surolia, Huashi Li, Zheng Wang, Gang Liu, Tejaswini Kulkarni, Keith Wille, Victor J. Thannickal and A. Brent Carter, Division of Pulmonary, Allergy and Critical Care Medicine, UAB Department of Medicine; Adriana V.F. Massicano and Suzanne E. Lapi, UAB Department of Radiology; James A. Mobley, UAB Department of Surgery; Santanu Mondal and Paul R. Thompson, University of Massachusetts Medical School, Worcester, Massachusetts; Joao A. de Andrade, Vanderbilt University Medical Center, Nashville, Tennessee; Scott A. Coonrod, College of Veterinary Medicine, Cornell University, Ithaca, New York; and Mohammad Athar, UAB Department of Dermatology.

Support came from National Institutes of Health grants ES027723, ES029981, ES015981-13, ES030246, HL114470, CA013148 and GM118112; and from Department of Veteran Affairs grant 1 I01 CX001715-01.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.